Skip to main content

Transcatheter Aortic Valve Implantation (TAVI)

  • Chapter
  • First Online:
Aortic Regurgitation

Abstract

Transcatheter aortic valve implantation (TAVI or TAVR) was developed as an alternative to surgical aortic valve replacement (SAVR) for inoperable or high-risk patients. Originally, this method was intended for the treatment of patients with aortic stenosis. Currently, there are several types of valves implanted percutaneously. The periprocedural complications of TAVI are not frequent. Using the second-generation or third-generation valves, the results of TAVI are improving and therefore TAVI is currently recommended also for intermediate-risk patients. For several reasons, TAVI in patients with AR is still problematic and is a subject of clinical research.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.

    Article  CAS  PubMed  Google Scholar 

  2. Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA. 2014;311:1503–14.

    Article  PubMed  Google Scholar 

  3. Wendler O, Schymik G, Treede H, et al. SOURCE 3 registry: design and 30-day results of the European postapproval registry of the latest generation of the SAPIEN 3 transcatheter heart valve. Circulation. 2017;135:1123–32.

    Article  PubMed  Google Scholar 

  4. Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387:2218–25.

    Article  PubMed  Google Scholar 

  5. Grube E, Van Mieghem NM, Bleiziffer S, et al. Clinical outcomes with a repositionable self-expanding transcatheter aortic valve prosthesis: the International FORWARD Study. J Am Coll Cardiol. 2017;70:845–53.

    Article  PubMed  Google Scholar 

  6. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J. 2003;24:1231–43.

    Article  PubMed  Google Scholar 

  7. D’Ancona G, Pasic M, Buz S, et al. TAVI for pure aortic valve insufficiency in a patient with a left ventricular assist device. Ann Thorac Surg. 2012;93:e89–91.

    Article  PubMed  Google Scholar 

  8. Roy DA, Schaefer U, Guetta V, et al. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. J Am Coll Cardiol. 2013;61:1577–84.

    Article  PubMed  Google Scholar 

  9. Testa L, Latib A, Rossi ML, et al. CoreValve implantation for severe aortic regurgitation: a multicentre registry. EuroIntervention. 2014;10:739–45.

    Article  PubMed  Google Scholar 

  10. Seiffert M, Diemert P, Koschyk D, et al. Transapical implantation of a second-generation transcatheter heart valve in patients with noncalcified aortic regurgitation. JACC Cardiovasc Interv. 2013;6:590–7.

    Article  PubMed  Google Scholar 

  11. Seiffert M, Bader R, Kappert U, et al. Initial German experience with transapical implantation of a second-generation transcatheter heart valve for the treatment of aortic regurgitation. JACC Cardiovasc Interv. 2014;7:1168–74.

    Article  PubMed  Google Scholar 

  12. Babaliaros V, Cribier A. The expansion of transcatheter technology to treat aortic insufficiency: everything old becomes new again. JACC Cardiovasc Interv. 2014;7:1175–6.

    Article  PubMed  Google Scholar 

  13. Barbanti M, Ye J, Pasupati S, et al. The Helio transcatheter aortic dock for patients with aortic regurgitation. EuroIntervention. 2013;9(Suppl):S91–4.

    Article  PubMed  Google Scholar 

  14. Pasupati S, Devlin G, Davis M, et al. Transcatheter solution for pure aortic insufficiency. JACC Cardiovasc Imaging. 2014;7:315–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Miroslav Brtko M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Brtko, M. (2018). Transcatheter Aortic Valve Implantation (TAVI). In: Vojacek, J., Zacek, P., Dominik, J. (eds) Aortic Regurgitation. Springer, Cham. https://doi.org/10.1007/978-3-319-74213-7_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-74213-7_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-74212-0

  • Online ISBN: 978-3-319-74213-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics